We support immune tolerance cell therapy for multiple sclerosis

Multiple sclerosis (MS) affects 50,000 patients in Spain and 2.5 million in the world, but there are currently no therapies that can cure this illness.

The GAEM Foundation, thanks to the cooperation of the ”la Caixa” Foundation, has begun specific antigen therapy with tolerised dendritic cells.

Immune Tolerance Cell Therapy Project GAEM Foundation

The goal of the project is to develop an effective personalised therapy with less risk of side effects for patients with multiple sclerosis (MS) and neuromyelitis optica (NMO).

This therapy uses dendritic cells loaded with myelin peptides to regulate the auto-immune attack on the myelin. This stops the disease progressing and therefore prevents physical and mental deterioration in people suffering MS.